Coronary Primary Prevention Trial
Author :
Publisher :
Page : 2 pages
File Size : 15,45 MB
Release : 1984
Category : Coronary heart disease
ISBN :
Author :
Publisher :
Page : 2 pages
File Size : 15,45 MB
Release : 1984
Category : Coronary heart disease
ISBN :
Author : Institute of Medicine
Publisher : National Academies Press
Page : 200 pages
File Size : 39,26 MB
Release : 2011-08-26
Category : Medical
ISBN : 0309212197
Chronic diseases are common and costly, yet they are also among the most preventable health problems. Comprehensive and accurate disease surveillance systems are needed to implement successful efforts which will reduce the burden of chronic diseases on the U.S. population. A number of sources of surveillance data-including population surveys, cohort studies, disease registries, administrative health data, and vital statistics-contribute critical information about chronic disease. But no central surveillance system provides the information needed to analyze how chronic disease impacts the U.S. population, to identify public health priorities, or to track the progress of preventive efforts. A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases outlines a conceptual framework for building a national chronic disease surveillance system focused primarily on cardiovascular and chronic lung diseases. This system should be capable of providing data on disparities in incidence and prevalence of the diseases by race, ethnicity, socioeconomic status, and geographic region, along with data on disease risk factors, clinical care delivery, and functional health outcomes. This coordinated surveillance system is needed to integrate and expand existing information across the multiple levels of decision making in order to generate actionable, timely knowledge for a range of stakeholders at the local, state or regional, and national levels. The recommendations presented in A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases focus on data collection, resource allocation, monitoring activities, and implementation. The report also recommends that systems evolve along with new knowledge about emerging risk factors, advancing technologies, and new understanding of the basis for disease. This report will inform decision-making among federal health agencies, especially the Department of Health and Human Services; public health and clinical practitioners; non-governmental organizations; and policy makers, among others.
Author : Nalini Jairath
Publisher : Saunders
Page : 362 pages
File Size : 20,47 MB
Release : 1999
Category : Medical
ISBN :
No other book delves as deeply into the important role the nurse plays in the management of risk factors for coronary heart disease. Written specifically for nurses, it provides the skills necessary to prevent and reduce the risk of coronary heart disease and limit its damaging effects. This text helps nurses teach at-risk patients and patient populations to minimize such factors as elevated serum cholesterol, smoking, and a sedentary lifestyle. Nurses will also learn how to teach patients to help themselves through sensitization activities, patient education, stress management, and behavior modification skills training. Interventions can be used in any nursing environment...hospitals, cardiac rehabilitation programs, or outpatient settings.
Author : United States. Public Health Service. Office of the Surgeon General
Publisher :
Page : 728 pages
File Size : 14,78 MB
Release : 2010
Category : Government publications
ISBN :
This report considers the biological and behavioral mechanisms that may underlie the pathogenicity of tobacco smoke. Many Surgeon General's reports have considered research findings on mechanisms in assessing the biological plausibility of associations observed in epidemiologic studies. Mechanisms of disease are important because they may provide plausibility, which is one of the guideline criteria for assessing evidence on causation. This report specifically reviews the evidence on the potential mechanisms by which smoking causes diseases and considers whether a mechanism is likely to be operative in the production of human disease by tobacco smoke. This evidence is relevant to understanding how smoking causes disease, to identifying those who may be particularly susceptible, and to assessing the potential risks of tobacco products.
Author : Dorairaj Prabhakaran
Publisher : World Bank Publications
Page : 948 pages
File Size : 11,73 MB
Release : 2017-11-17
Category : Medical
ISBN : 1464805202
Cardiovascular, respiratory, and related conditions cause more than 40 percent of all deaths globally, and their substantial burden is rising, particularly in low- and middle-income countries (LMICs). Their burden extends well beyond health effects to include significant economic and societal consequences. Most of these conditions are related, share risk factors, and have common control measures at the clinical, population, and policy levels. Lives can be extended and improved when these diseases are prevented, detected, and managed. This volume summarizes current knowledge and presents evidence-based interventions that are effective, cost-effective, and scalable in LMICs.
Author : Institute of Medicine
Publisher : National Academies Press
Page : 304 pages
File Size : 32,46 MB
Release : 2010-12-04
Category : Medical
ISBN : 030915698X
The Social Security Administration (SSA) uses a screening tool called the Listing of Impairments to identify claimants who are so severely impaired that they cannot work at all and thus immediately qualify for benefits. In this report, the IOM makes several recommendations for improving SSA's capacity to determine disability benefits more quickly and efficiently using the Listings.
Author : Pekka Jousilahti
Publisher :
Page : 127 pages
File Size : 27,54 MB
Release : 1997
Category :
ISBN : 9789517400695
Author : Michael J. Wilkinson
Publisher : Springer Nature
Page : 279 pages
File Size : 45,53 MB
Release : 2021-08-13
Category : Medical
ISBN : 3030781771
This book discusses all aspects of non-pharmacologic approaches to primary and secondary CVD prevention. It highlights the strength of evidence for particular diet styles in CVD prevention, including plant-based diets, the Mediterranean diet, the DASH diet, and low-carbohydrate diets. Chapters present evidence and future directions for diet and nutrition in diseases related to CVD, such as dyslipidemia, cardiometabolic disease (pre-diabetes, the metabolic syndrome, type-2 diabetes mellitus), and obesity. Finally, the book reviews novel and emerging aspects of dietary intervention in CVD prevention, such as dietary approaches to inflammation and the role of the microbiome in CVD. Up-to-date, evidence-based, and clinically oriented, Prevention and Treatment of Cardiovascular Disease: Nutritional and Dietary Approaches is an essential resource for physicians, residents, fellows, and medical students in cardiology, clinical nutrition, family medicine, endocrinology, and lipidology.
Author : Johnny Chahine
Publisher : BoD – Books on Demand
Page : 230 pages
File Size : 32,61 MB
Release : 2022-04-06
Category : Medical
ISBN : 1839687088
Risk Factors for Cardiovascular Disease raises awareness about the importance of early recognition and prevention of modifiable cardiovascular risk factors. Some non-modifiable factors, like diabetes, can even be impacted by lifestyle modification (like weight loss) early in the disease. This book also describes cardiovascular risk factors in different patient populations and work settings.
Author : Antonio M. Gotto Jr.
Publisher : Springer Science & Business Media
Page : 370 pages
File Size : 50,11 MB
Release : 2012-12-06
Category : Medical
ISBN : 9401150222
This volume is a collection of the most significant contributions to the 4th International Symposium on MULTIPLE RISK FACTORS IN CARDIOVASCULAR DISEASE: STRATEGIES OF PREVENTION OF CORONARY HEART DISEASE, CARDIAC F AlLURE, AND STROKE held in Washington, D. C. in April 1997. The meeting focused on the risk factors for cardiovascular disease and their interactions. The need for this symposium is based on the epidemiological, clinical, and biological evidence that individuals from industrialized countries often possess two or more risk factors which synergistically increase the global risk profile. This has become more evident in recent years with the increase in life expectancy of populations in the industrialized countries. The evidence that a combination of risk factors confers a very high risk of developing cardiovascular diseases, is of pivotal interest in the process of detection of patients who will benefit the most from pharmacological treatment. Many recent epidemiological data identifying the intrinsic and environmental factors contributing to the development of atherosclerosis are discussed. These results, in parallel with basic and clinical research, underline atherosclerosis as a complex and multifactorial process involving the influences of lipids, including lipoprotein subfractions, blood pressure rheologic forces, carbohydrate tolerance, and thrombogenic factors, including fibrinogen, tissue factor, PAl-I, and homocysteine. Furthennore, the risk associated with anyone of these risk factors varies widely depending on the level of the associated atherogenic risk factors. Hyper cholesterolemia and hypertriglyceridemia, for instance, are more common than would be expected by chance among hypertensive patients.